MEGAN ALLMAN: Open Payments
NPI 1780163709 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 70 payments from 32 companies in 2025. Trend: 2023 $611 · 2024 $1,427 · 2025 $1,660
Food & beverage: $1,580Education: $80
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $163 |
| Amgen Inc. | 1 | $125 |
| SOBI, INC | 3 | $123 |
| Janssen Biotech, Inc. | 5 | $118 |
| ABBVIE INC. | 5 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| Merck Sharp & Dohme LLC | 3 | $79 |
| Eisai Inc. | 3 | $70 |
| Daiichi Sankyo Inc. | 3 | $69 |
| Celgene Corporation | 3 | $61 |
Products named: OTEZLA, ERLEADA, SCEMBLIX, KEYTRUDA, Lenvima, OPDIVO, EMRELIS, Enhertu.
Industry payments across SC — which companies pay providers there.
